Semaglutide

Semaglutide – Research Peptide for Metabolic, Weight Loss & Diabetes Studies
Semaglutide is a GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes and obesity. In research, it is widely studied for its effects on insulin sensitivity, appetite regulation, and weight loss. Its ability to mimic natural GLP-1 makes it an attractive compound for experimental use in metabolic and endocrinological models.

Benefits of Semaglutide

• Mimics GLP-1 to regulate blood glucose and insulin levels
• Studied for strong appetite-suppressing and weight loss effects
• Promotes delayed gastric emptying and increased satiety
• Popular in obesity and metabolic disorder research
• May improve cardiovascular risk markers in experimental settings
• Long half-life allows once-weekly research applications

How does Semaglutide work?
Semaglutide binds to and activates the GLP-1 receptor, which regulates insulin secretion and slows digestion. This leads to reduced appetite, lower caloric intake, and improved metabolic outcomes in preclinical models. Researchers use it to explore pathways of weight regulation, diabetes control, and neuroendocrine signaling.

Dosage, Preparation & Storage

• Use: Supplied in lyophilized powder form and should be mixed with bacteriostatic water (included)
• Recommended mixing ratio: 1 ml bac water to each vial (adjustable based on preferred concentration)
• Use our peptide calculator to determine accurate doses for study protocols
• Storage: After mixing, refrigerate (2–8 °C)
• Shelf life: Up to 30 days post-reconstitution

Purity & Quality

Each batch is thoroughly tested for purity and sterile production.

Our Semaglutide is produced to the highest standards and tested by an independent third party to ensure maximum purity and quality.

Legal Disclaimer
This product is intended for scientific research use only. It is not approved for human consumption or clinical use.